Stay updated on Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.

Latest updates to the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry, v3.6.5, was added to the study history. The previous revision, v3.6.4, was removed from the list.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.6.4 and removes Revision: v3.6.3. This updates the page to reflect the latest software release and the corresponding history record.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry, Revision: v3.6.3, was added to the study record history, updating the version history from v3.6.2. This reflects an administrative update to the record rather than changes to study data.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision label (v3.6.2) is added to the history, replacing the previous v3.6.0 entry. This reflects an update to the page's revision metadata rather than substantive study information.SummaryDifference0.1%

- Check71 days agoChange DetectedThe study history now includes a new revision entry labeled v3.6.0 and the removal of the previous v3.5.5 entry. A note stating 'No longer looking for participants' was added, indicating that recruitment has ended.SummaryDifference0.2%

- Check78 days agoChange DetectedThe history log now shows a new revision entry (v3.5.5) and removes the previous revision (v3.5.4), indicating an update to the study history documentation.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.